Search results for:
ocrelizumab-hyaluronidase
ocrelizumab-hyaluronidase
| Drug Name |
Form |
Strength |
Ambulatory Use Only |
Ambulatory Restrictions |
Inpatient Restrictions |
Non-Formulary |
| Ocrevus Zunovo |
SOLUTION, SUBCUTANEOUS |
920 mg-23,000 units/23 mL |
|
|
|
|
Last updated: Sep. 26, 2025